Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
Narayanan S, Vuckovic S, Bergman O, Wirka R, Verdezoto Mosquera J, Chen QS, Baldassarre D, Tremoli E, Veglia F, Lengquist M, Aherahrrou R, Razuvaev A, Gigante B, Björck HM, Miller CL, Quertermous T, Hedin U, Matic L.
Narayanan S, et al. Among authors: chen qs.
Eur Heart J. 2025 Jan 16;46(3):308-322. doi: 10.1093/eurheartj/ehae768.
Eur Heart J. 2025.
PMID: 39552248
Free PMC article.